Katsuhiko Hatazawa
Directeur/Membre du Conseil chez Spera Pharma, Inc.
Provenance du réseau au premier degré de Katsuhiko Hatazawa
Entité | Type d'entité | Industrie | |
---|---|---|---|
Spera Pharma, Inc.
Spera Pharma, Inc. Pharmaceuticals: MajorHealth Technology Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan.
3
| Subsidiary | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Katsuhiko Hatazawa via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Public Communications Contact | |
Idorsia Pharmaceuticals Japan Ltd.
Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Pharmaceuticals: Major | Director/Board Member | |
ADVANCE LOGISTICS INVESTMENT CORPORATION | Real Estate Investment Trusts | Corporate Officer/Principal | |
Keio University | College/University | Graduate Degree | |
Seiwa Corp. (Nippon Gear) | Director/Board Member | ||
SCOHIA PHARMA, Inc.
SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Miscellaneous Commercial Services | Director/Board Member | |
ASTENA HOLDINGS CO., LTD. | Pharmaceuticals: Other | Comptroller/Controller/Auditor | |
Iwaki Seiyaku Co., Ltd.
Iwaki Seiyaku Co., Ltd. Pharmaceuticals: MajorHealth Technology Iwaki Seiyaku Co., Ltd. manufactures and sells pharmaceuticals. Its products include over-the-counter drugs, veterinary drugs, pharmaceutical intermediates, food additives, cosmetic raw materials, dyes, and pigment intermediates. The company was founded on January 28, 1931 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Comptroller/Controller/Auditor |
Statistiques
Internationale
Japon | 9 |
Sectorielle
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Opérationnelle
Director/Board Member | 8 |
Comptroller/Controller/Auditor | 3 |
Corporate Officer/Principal | 3 |
Public Communications Contact | 1 |
Chief Executive Officer | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Katsuhiko Hatazawa
- Connexions Sociétés